Table 2 Total costs in 2017 prices by trial arm
From: Cost-effectiveness of adrenaline for out-of-hospital cardiac arrest
Assessment period | Category | Adrenaline (n = 4015) | Placebo (n = 3999) | Adrenaline versus placebo | |||
|---|---|---|---|---|---|---|---|
N | Mean (SE), £ | N | Mean (SE), £ | Mean cost difference (bootstrap 95% CI), £ | P value | ||
0–6 months | Hospitalisation costs (NHS and PSS) | 4006 | 2669 (179) | 3988 | 1460 (129) | 1209 (804, 1660) | < 0.001 |
Non-hospitalisation costs (NHS and PSS) | 3934 | 1785 (21) | 3926 | 1678 (13) | 107 (61, 155) | < 0.001 | |
Non-NHS and PSS costs | 3956 | 51 (15) | 3952 | 15 (6) | 36 (8, 69) | 0.01 | |
Total NHS and PSS costs | 3934 | 3789 (121) | 3926 | 2698 (94) | 1091 (807, 1398) | < 0.001 | |
Total societal costs | 3933 | 3829 (124) | 3925 | 2687 (92) | 1143 (861, 1451) | < 0.001 | |